Foresite Capital Opportunity Management V, LLC Gemini Therapeutics, Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Gemini Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 2,435,125 shares of GMTX stock, worth $59.3 Million. This represents 11.99% of its overall portfolio holdings.
Number of Shares
2,435,125
Previous 2,435,125
-0.0%
Holding current value
$59.3 Million
Previous $4.12 Million
2.94%
% of portfolio
11.99%
Previous 10.37%
Shares
1 transactions
Others Institutions Holding GMTX
# of Institutions
1Shares Held
2.44MCall Options Held
0Put Options Held
0About Gemini Therapeutics, Inc.
- Ticker GMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,244,500
- Market Cap $1.05B
- Description
- Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...